Medication Adherence, Older Adults, Stroke
Conditions
Brief summary
Stroke is a major cause of morbidity and mortality, especially in low and middle income countries including Iran. Patients with recent stroke or TIA are at high risk for new vascular events. Several evidence based strategies in secondary prevention of stroke are available but frequently underused. The study is aimed to evaluate an intervention to improve patients with Stroke.
Interventions
Sponsors
Qazvin University Of Medical Sciences
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* aged 65 years or older * able to give informed consent
Exclusion criteria
* recurrent stroke * a diagnosis of subarachnoid haemorrhage * significant impairments precluding participation - inability to give informed consent * another condition likely to impact their participation in the trial (e.g. life-threatening condition other than cardiovascular disease) * expected discharge to hospital/nursing home setting
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| changes in Patient-reported Adherence Medication Adherence Rating Scale | changes from baseline, 6 Months, 12 months and 18 months follow-up | a self-report measure of adherence (Medication Adherence Report Scale \[MARS-5\]) will be used . |
| changes in blood pressure | changes from baseline, 6 Months, 12 months and 18 months follow-up | — |
| changes in low-density lipoprotein (LDL)-cholesterol level | changes from baseline, 6 Months, 12 months and 18 months follow-up | — |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Changes in quality of life | changes from baseline, 6 Months, 12 months and 18 months follow-up | The Short Form (36) Health Survey is used to assess patient's quality of life |
| Changes in perceived behavioral control to medication adherence | changes from baseline, 6 Months, 12 months and 18 months follow-up | The perceived behavioral control to medication adherence is assessed through a self-report instrument |
| Changes in intention to medication adherence | changes from baseline, 6 Months, 12 months and 18 months follow-up | — |
| Changes in Illness Perceptions | changes from baseline, 6 Months, 12 months and 18 months follow-up | the Brief Illness Perception. Questionnaire (Brief IPQ) is used to assess patient's illness representation |
| Changes in Self-monitoring to medication adherence | changes from baseline, 6 Months, 12 months and 18 months follow-up | The Self-monitoring to medication adherence is assessed through a self-report instrument |
| Changes in Action Plan | changes from baseline, 6 Months, 12 months and 18 months follow-up | The action plan is assessed by a self-reported questionnaire. it is used by the patients before, at baseline, six months, twelve months and eighteen months after the intervention |
| Changes in Coping Plan | changes from baseline, 6 Months, 12 months and 18 months follow-up | The coping plan is assessed by a self-reported questionnaire. It is used by the patients before, at baseline, six months, twelve months and eighteen months after the intervention |
Countries
Iran
Outcome results
None listed